Elisabeth Baugh, Ovarian Cancer Champion, to Retire
CCRA members congratulate Elisabeth Baugh on her pending retirement as CEO of Ovarian Cancer Canada. Elisabeth has been at the helm of the organization since its founding. Under Elisabeth’s leadership, Ovarian Cancer Canada has grown its national presence and her commitment to women living with ovarian cancer and passion for advancing game-changing research helped secure federal and partnered funding for OvCAN. This initiative is focused on finding the best research models for ovarian cancer, identifying the most promising novel treatments, and advancing clinical trials using a personalized medicine approach.
Beyond Canada, Elisabeth chaired the first ever World Ovarian Cancer Day in 2013 and has served as chair of the World Ovarian Cancer Coalition since its inception, working to increase the international profile of this important cause.
We wish Elisabeth the very best in upcoming retirement. She will be missed at the CCRA table.

CCRA released its latest reports on the investment in cancer research. In addition to the overview report, there are brief reports on the research investments made in childhood and adolescent cancers, cancer risk and prevention, cancer survivorship, palliative and end-of-life cancer care and translational research. Reports are av...
The CCRA Awards, initiated in 2011, recognize and celebrate, on a biennial basis, individuals who have had a remarkable impact on cancer research and the cancer research community. We are seeking nominees for our four award categories: outstanding research, distinguish...